Total Payments
$981.38
2024 Payments
$561.01
Companies
14
Transactions
32
Medicare Patients
1,584
Medicare Billing
$445,354
Payment Breakdown by Category
Food & Beverage$981.38 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $981.38 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $314.56 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $180.97 | 6 | $0 (2024) |
| Shionogi Inc | $131.09 | 2 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $57.14 | 1 | $0 (2024) |
| ABBVIE INC. | $55.13 | 3 | $0 (2024) |
| La Jolla Pharmaceutical Company | $44.13 | 2 | $0 (2024) |
| Abbott Laboratories | $41.41 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $39.65 | 2 | $0 (2023) |
| Chiesi USA, Inc. | $34.50 | 2 | $0 (2024) |
| Inari Medical, Inc. | $23.45 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $561.01 | 14 | Gilead Sciences, Inc. ($151.80) |
| 2023 | $294.82 | 11 | Gilead Sciences, Inc. ($162.76) |
| 2020 | $11.68 | 1 | PFIZER INC. ($11.68) |
| 2018 | $84.18 | 4 | Abbott Laboratories ($41.41) |
| 2017 | $29.69 | 2 | Novartis Pharmaceuticals Corporation ($16.44) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 10/02/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 09/19/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: VTE | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: COVID-19 | ||||||
| 09/04/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.32 | General |
| 03/27/2024 | C. R. Bard, Inc. & Subsidiaries | Arctic Sun 5000 (Device) | Food and Beverage | In-kind items and services | $57.14 | General |
| Category: Catheter Care and Medication Delivery | ||||||
| 03/11/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.65 | General |
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $40.92 | General |
| Category: Rare Disease | ||||||
| 01/22/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $117.87 | General |
| Category: Infections and Infectious Diseases | ||||||
| 01/21/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $82.94 | General |
| Category: Rare Disease | ||||||
| 01/08/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Rare Disease | ||||||
| 12/20/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: COVID-19 | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 11/27/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/20/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: COVID-19 | ||||||
| 10/12/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $17.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/05/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/20/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: COVID-19 | ||||||
| 08/19/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 04/03/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: COVID-19 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 327 | 684 | $552,950 | $106,163 |
| 2022 | 6 | 384 | 779 | $364,729 | $109,604 |
| 2021 | 4 | 364 | 735 | $273,581 | $110,800 |
| 2020 | 10 | 509 | 996 | $298,304 | $118,787 |
Total Patients
1,584
Total Services
3,194
Medicare Billing
$445,354
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 209 | 517 | $498,655 | $91,630 | 18.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 95 | $20,854 | $9,074 | 43.5% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 27 | 28 | $16,855 | $1,895 | 11.2% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 12 | 13 | $8,627 | $1,542 | 17.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 12 | 17 | $5,629 | $1,504 | 26.7% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 13 | 14 | $2,330 | $517.33 | 22.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 188 | 496 | $296,112 | $87,003 | 29.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 98 | 168 | $36,288 | $13,956 | 38.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 46 | 57 | $14,820 | $5,189 | 35.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 27 | 28 | $13,720 | $1,981 | 14.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 17 | $2,567 | $998.91 | 38.9% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 12 | 13 | $1,222 | $476.40 | 39.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 191 | 494 | $223,854 | $89,549 | 40.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 114 | 174 | $31,726 | $15,227 | 48.0% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 46 | 54 | $12,387 | $5,077 | 41.0% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 13 | 13 | $5,614 | $947.44 | 16.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 120 | 341 | $127,749 | $66,255 | 51.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 149 | 365 | $72,909 | $24,434 | 33.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 81 | 126 | $30,728 | $11,942 | 38.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 24 | $12,978 | $4,125 | 31.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 30 | 30 | $13,262 | $3,565 | 26.9% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 29 | 30 | $20,280 | $2,295 | 11.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 26 | 26 | $7,254 | $2,277 | 31.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 27 | 28 | $5,794 | $1,808 | 31.2% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 12 | 12 | $3,990 | $1,542 | 38.7% |
About Dr. Edward Gray, DO
Dr. Edward Gray, DO is a Critical Care Medicine healthcare provider based in East Norriton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1588843015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Gray, DO has received a total of $981.38 in payments from pharmaceutical and medical device companies, with $561.01 received in 2024. These payments were reported across 32 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($981.38).
As a Medicare-enrolled provider, Gray has provided services to 1,584 Medicare beneficiaries, totaling 3,194 services with total Medicare billing of $445,354. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine
- Location East Norriton, PA
- Active Since 11/01/2007
- Last Updated 05/28/2020
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588843015
Products in Payments
- Veklury (Drug) $284.59
- ANDEXXA (Biological) $180.97
- Fetroja (Drug) $131.09
- Arctic Sun 5000 (Device) $57.14
- AVYCAZ (Drug) $55.13
- GIAPREZA (Drug) $44.13
- HeartMate (Device) $41.41
- XARELTO (Drug) $39.65
- CLEVIPREX (Drug) $34.50
- FLOWTRIEVER CATHETER, S (Device) $23.45
- Kcentra (Biological) $17.98
- ENTRESTO (Drug) $16.44
- Precision Flow (Device) $13.25
- ELIQUIS (Drug) $11.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.